Texas sues J&J's Janssen Pharma

The state of Texas is suing Johnson & Johnson's Janssen Pharmaceuticals, alleging that the drug company used Texas mental health officials as "pitchmen" and carried out other unseemly tactics to get its antipsychotic medication, Risperdal, on Texas's Medicaid preferred provider drug list. In addition, the state is accusing New Jersey-based Janssen of supplying phony advocacy groups and making other attempts to influence positioning of the medication, essentially defrauding the state over the last 10 years. Report

Suggested Articles

It's taken years for Amarin's Vascepa to prove itself as a game-changing treatment for CV disease. An FDA committee may have just punched its pass.

Continuing its expansion efforts, Japan’s Fujifilm will make a major investment in its U.S. gene therapy operation in Texas.

With a potential approval next year in the up-and-coming NASH field, Intercept is staffing up its sales team and starting talks with payers.